Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations

Chad A. Hamilton, Bhavana Pothuri, Rebecca C. Arend, Floor J. Backes, Paola A. Gehrig, Pamela T. Soliman, J. Spencer Thompson, Renata R. Urban, William M. Burke

Research output: Contribution to journalReview articlepeer-review

41 Scopus citations

Abstract

INTRODUCTION: In 2014, the Society of Gynecologic Oncology's Clinical Practice Committee published a clinical update reviewing the treatment of women with endometrial cancer. At that time, there had been significant advances in the diagnosis, work-up, surgical management, and available treatment options allowing for more optimal care of affected women. Despite these advances, the incidence of endometrial cancer as well as the deaths attributable to the disease have continued to rise; from 1987 to 2014 there has been a 75% increase in cases and almost 300% increase in endometrial cancer deaths. Fortunately, since then, there has been progress in the treatment of patients with endometrial cancer with increased utilization of molecular pathology, greater understanding of genetic predisposition, enhanced methods for lymph node assessment, a broader understanding of the efficacy of radiation and chemotherapy, and a more efficient approach to survivorship and surveillance. The purpose of this document is to present a comprehensive review of this progress. MANUSCRIPT DEVELOPMENT PROCESS: The authors reviewed the available evidence, contributed to the development of this manuscript, provided critical review of the guidelines, and finalized the manuscript recommendations. The review was also presented to and approved by the Society of Gynecologic Oncology (SGO) Clinical Practice Committee, SGO Publications Committee, and the SGO board members prior to submission for publication. The recommendations for this manuscript were developed by a panel of gynecologic oncologists who were members of the SGO Clinical Practice and Education Committees. Panelists reviewed and considered evidence from current uterine cancer literature. The terminology used in these guidelines was adopted from the ASCCP management guidelines [1] using a two-part rating system to grade the strength of recommendation and quality of evidence (Table 1). The rating for each recommendation is given in parentheses.

Original languageEnglish (US)
Pages (from-to)817-826
Number of pages10
JournalGynecologic oncology
Volume160
Issue number3
DOIs
StatePublished - Mar 1 2021

Keywords

  • Chemotherapy
  • Endometrial cancer
  • Fertility preservation
  • Molecular pathology
  • Part I
  • Part II
  • Recurrence
  • Risk stratification
  • Surgery
  • Surveillance
  • Survivorship

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations'. Together they form a unique fingerprint.

Cite this